AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,918.00
Market cap: ₹14,795 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 87.2×Sector 47.3×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Management Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

18 Sep 2026 18:03 IST BSE

Legal & Regulatory

AstraZeneca Pharma India Legal & Regulatory

AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.

Value: ₹0.03 Cr
From: Registrar of Companies, Bengaluru, Karnataka

Read the filing ↗

18 Sep 2026 16:56 IST BSE

Legal & Regulatory

AstraZeneca Pharma India Legal & Regulatory

AstraZeneca Pharma disclosed a ₹1.88 lakh penalty from the Registrar of Companies due to a delay in filing Form MR-2.

Value: ₹0.02 Cr

Read the filing ↗

15 Sep 2026 12:00 IST BSE

Management Change

AstraZeneca Pharma India Management Change

AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.

Read the filing ↗